XML 65 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations - Schedule of Amounts Included in Discontinued Operations (Details) - USD ($)
3 Months Ended 12 Months Ended
Nov. 22, 2022
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Earnings from discontinued operations, net of tax                   $ 202,800,000 $ 291,400,000 $ 275,900,000
Gain on disposition of discontinued operations, net of tax                   3,356,300,000 55,900,000 0
Net earnings from discontinued operations   $ 1,681,100,000 $ 50,100,000 $ 43,800,000 $ 1,784,100,000 $ 120,700,000 $ 78,700,000 $ 81,900,000 $ 66,000,000.0 3,559,100,000 347,300,000 275,900,000
Held-for-sale or Disposed of by Sale | TransCore Holdings Inc, Zetec, and Civco Radiotherapy                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Net revenues                   100,400,000 638,000,000.0 672,900,000
Cost of sales                   71,200,000 372,900,000 400,700,000
Gross profit                   29,200,000 265,100,000 272,200,000
Selling, general and administrative expenses                   19,900,000 124,000,000.0 114,600,000
Income from operations                   9,300,000 141,100,000 157,600,000
Other income, net                   100,000 1,500,000 300,000
Earnings before income taxes                   9,400,000 142,600,000 157,900,000
Income taxes                   (6,200,000) 28,500,000 33,700,000
Earnings from discontinued operations, net of tax                   15,600,000 114,100,000 124,200,000
Gain on disposition of discontinued operations, net of tax                   1,717,500,000 55,900,000 0
Net earnings from discontinued operations                   1,733,100,000 170,000,000.0 124,200,000
Stock-based compensation expense                   4,500,000 900,000  
Depreciation and amortization                   0 5,200,000 7,900,000
Held-for-sale or Disposed of by Sale | TransCore Holdings Inc, Zetec, and Civco Radiotherapy | Selling, General and Administrative Expenses                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Stock-based compensation expense                   900,000 5,400,000 4,800,000
Held-for-sale or Disposed of by Sale | Indicor                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Net revenues                   916,100,000 944,000,000.0 831,800,000
Cost of sales                   432,100,000 434,200,000 389,300,000
Gross profit                   484,000,000.0 509,800,000 442,500,000
Selling, general and administrative expenses                   250,500,000 265,700,000 251,900,000
Impairment of intangible assets                   0 5,100,000 0
Income from operations                   233,500,000 239,000,000.0 190,600,000
Other income, net                   (700,000) 100,000 (500,000)
Earnings before income taxes $ 2,046,000,000                 232,800,000 239,100,000 190,100,000
Income taxes $ 407,200,000                 45,600,000 61,800,000 38,400,000
Earnings from discontinued operations, net of tax                   187,200,000 177,300,000 151,700,000
Gain on disposition of discontinued operations, net of tax                   1,638,800,000 0 0
Net earnings from discontinued operations                   1,826,000,000 177,300,000 151,700,000
Stock-based compensation expense                   10,300,000 13,100,000 8,700,000
Depreciation and amortization                   $ 6,400,000 $ 18,200,000 $ 21,300,000